Mavacamten improved cardiac functionand symptoms in patients with obstructive Hypertrophic Cardiomyopathy (HCM) in MAVA-LTE and VALOR-HCM, while favorable circulating proteomic profile changes were observed following mavacamnten treatment in EXPLORER-HCM.
SUSTAINED FAVORABLE IMPACT OF MAVACAMTEN ON BIOMARKERS FOR CARDIOPULMONARY STRESS AND HEMOLYSIS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY FROM THE MAVA-LTE (EXPLORER COHORT) AND VALOR-HCM STUDIES / Wang, Zhaoqing; Yao, Chen; Anderson, Warren; Balaratnam, Ganesh; Lampl, Kathy; He, Aiqing; KIM, MINJI; Schafer, Peter; Desai, Milind Y.; Olivotto, Iacopo. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - ELETTRONICO. - 85:(2025), pp. 0-0. [10.1016/s0735-1097(25)01736-x]
SUSTAINED FAVORABLE IMPACT OF MAVACAMTEN ON BIOMARKERS FOR CARDIOPULMONARY STRESS AND HEMOLYSIS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY FROM THE MAVA-LTE (EXPLORER COHORT) AND VALOR-HCM STUDIES
Yao, Chen;Olivotto, Iacopo
2025
Abstract
Mavacamten improved cardiac functionand symptoms in patients with obstructive Hypertrophic Cardiomyopathy (HCM) in MAVA-LTE and VALOR-HCM, while favorable circulating proteomic profile changes were observed following mavacamnten treatment in EXPLORER-HCM.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.